Laura E. Case

9.5k total citations · 4 hit papers
86 papers, 6.0k citations indexed

About

Laura E. Case is a scholar working on Physiology, Rheumatology and Psychiatry and Mental health. According to data from OpenAlex, Laura E. Case has authored 86 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Physiology, 45 papers in Rheumatology and 28 papers in Psychiatry and Mental health. Recurrent topics in Laura E. Case's work include Lysosomal Storage Disorders Research (55 papers), Glycogen Storage Diseases and Myoclonus (45 papers) and Child Nutrition and Feeding Issues (17 papers). Laura E. Case is often cited by papers focused on Lysosomal Storage Disorders Research (55 papers), Glycogen Storage Diseases and Myoclonus (45 papers) and Child Nutrition and Feeding Issues (17 papers). Laura E. Case collaborates with scholars based in United States, United Kingdom and Canada. Laura E. Case's co-authors include David J. Birnkrant, K. Bushby, Priya S. Kishnani, Paula R. Clemens, Jean Tomezsko, Shree Pandya, Linda Cripe, Frederic Shapiro, Carolyn M. Constantin and Craig M. McDonald and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PEDIATRICS.

In The Last Decade

Laura E. Case

83 papers receiving 5.8k citations

Hit Papers

Diagnosis and management of Duchenne muscular dystrophy, ... 2009 2026 2014 2020 2009 2009 2018 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
    2009 1.4k citations K. Bushby, Richard S. Finkel et al. The Lancet Neurology profile →
  2. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
    2009 785 citations K. Bushby, Richard S. Finkel et al. The Lancet Neurology profile →
  3. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management
    2018 781 citations David J. Birnkrant, K. Bushby et al. The Lancet Neurology profile →
  4. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management
    2018 651 citations David J. Birnkrant, K. Bushby et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura E. Case United States 28 3.4k 2.2k 1.3k 1.1k 925 86 6.0k
Paula R. Clemens United States 38 5.9k 1.7× 1.3k 0.6× 383 0.3× 1.2k 1.1× 501 0.5× 116 7.8k
Julaine Florence United States 36 2.9k 0.9× 783 0.4× 226 0.2× 1.4k 1.3× 646 0.7× 66 5.0k
Pieter A. van Doorn Netherlands 50 674 0.2× 2.9k 1.4× 1.8k 1.4× 563 0.5× 782 0.8× 197 9.1k
Anneke J. van der Kooi Netherlands 45 3.2k 0.9× 688 0.3× 340 0.3× 1.3k 1.2× 321 0.3× 151 6.4k
Wolfgang Müller‐Felber Germany 31 1.2k 0.4× 912 0.4× 750 0.6× 680 0.6× 320 0.3× 135 3.2k
Giuseppe Vita Italy 37 2.5k 0.7× 740 0.3× 287 0.2× 590 0.5× 323 0.3× 245 5.5k
Guiting Lin United States 49 1.6k 0.5× 505 0.2× 607 0.5× 1.5k 1.4× 2.5k 2.7× 186 7.1k
Izumi Nagata Japan 48 1.3k 0.4× 361 0.2× 1.5k 1.2× 420 0.4× 849 0.9× 356 8.4k
Katherine D. Mathews United States 38 4.3k 1.3× 522 0.2× 141 0.1× 738 0.7× 555 0.6× 175 5.9k
Elena Pegoraro Italy 41 3.8k 1.1× 592 0.3× 263 0.2× 1.1k 1.0× 175 0.2× 196 5.6k

Countries citing papers authored by Laura E. Case

Since Specialization
Citations

This map shows the geographic impact of Laura E. Case's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura E. Case with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura E. Case more than expected).

Fields of papers citing papers by Laura E. Case

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura E. Case. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura E. Case. The network helps show where Laura E. Case may publish in the future.

Co-authorship network of co-authors of Laura E. Case

This figure shows the co-authorship network connecting the top 25 collaborators of Laura E. Case. A scholar is included among the top collaborators of Laura E. Case based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura E. Case. Laura E. Case is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Case, Laura E., et al.. (2026). Lessons from late-onset Pompe disease identified by Newborn screening: A systematic review. Molecular Genetics and Metabolism. 147(4). 109762–109762.
2.
Kenney‐Jung, Daniel, Grace A. Stafford, Michael D. Malinzak, et al.. (2025). Infantile-onset Pompe disease entering adulthood: Insights from 2 decades of enzyme replacement therapy experience. Genetics in Medicine. 27(12). 101590–101590. 1 indexed citations
3.
Desai, Ankit K., et al.. (2024). Optimizing clinical outcomes: The journey of twins with CRIM-negative infantile-onset Pompe disease on high-dose enzyme replacement therapy and immunomodulation. Molecular Genetics and Metabolism Reports. 41. 101141–101141. 2 indexed citations
4.
Soler‐Alfonso, Claudia, Ariana L. Smith, Deeksha Bali, et al.. (2023). Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource. Molecular Genetics and Metabolism. 138(3). 107525–107525. 21 indexed citations
5.
Smith, Edward C., Sam Hopkins, Laura E. Case, et al.. (2023). Phase I study of liver depot gene therapy in late-onset Pompe disease. Molecular Therapy. 31(7). 1994–2004. 24 indexed citations
6.
Koch, Rebecca E., Claudia Soler‐Alfonso, Bridget Kiely, et al.. (2023). O18: A path forward for patients with glycogen branching enzyme deficiency: Consensus on diagnosing and managing glycogen storage disease type IV*. SHILAP Revista de lepidopterología. 1(1). 100114–100114. 1 indexed citations
7.
8.
9.
Case, Laura E., Stephanie DeArmey, Harrison N. Jones, et al.. (2020). Higher dosing of alglucosidase alfa improves outcomes in children with Pompe disease: a clinical study and review of the literature. Genetics in Medicine. 22(5). 898–907. 40 indexed citations
10.
11.
Jones, Harrison N., Maragatha Kuchibhatla, Lisa D. Hobson‐Webb, et al.. (2020). Respiratory muscle training in late-onset Pompe disease: Results of a sham-controlled clinical trial. Neuromuscular Disorders. 30(11). 904–914. 12 indexed citations
12.
Englander, Zoë A., Jessica Sun, Laura E. Case, et al.. (2015). Brain structural connectivity increases concurrent with functional improvement: Evidence from diffusion tensor MRI in children with cerebral palsy during therapy. NeuroImage Clinical. 7. 315–324. 46 indexed citations
13.
Case, Laura E., Carl Bjartmar, Claire Morgan, et al.. (2014). Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease. Neuromuscular Disorders. 25(4). 321–332. 44 indexed citations
14.
Krosschell, Kristin J., Jo Anne Maczulski, Charles Scott, et al.. (2013). Reliability and Validity of the TIMPSI for Infants With Spinal Muscular Atrophy Type I. Pediatric Physical Therapy. 25(2). 140–148. 11 indexed citations
15.
Whyte, MP, et al.. (2012). Fracture Burden In Adults With Hypophosphatasia. Revistes Científiques de la University of Barcelona (University of Barcelona). 51(1). 15. 1 indexed citations
16.
Case, Laura E., et al.. (2012). Infantile Pompe disease on ERT—Update on clinical presentation, musculoskeletal management, and exercise considerations. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 160C(1). 69–79. 57 indexed citations
17.
Horvath, Jeffrey J., Stephanie Austin, Harrison N. Jones, et al.. (2012). Bulbar muscle weakness and fatty lingual infiltration in glycogen storage disorder type IIIa. Molecular Genetics and Metabolism. 107(3). 496–500. 8 indexed citations
18.
Kishnani, Priya S., Stephanie Austin, Pamela Arn, et al.. (2010). Glycogen Storage Disease Type III diagnosis and management guidelines. Genetics in Medicine. 12(7). 446–463. 197 indexed citations
19.
Bushby, K., Richard S. Finkel, David J. Birnkrant, et al.. (2009). Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. The Lancet Neurology. 9(1). 77–93. 1378 indexed citations breakdown →
20.
Case, Laura E., Donald P. Frush, Stephanie DeArmey, et al.. (2007). Fractures in children with Pompe disease: a potentiallong-term complication. Pediatric Radiology. 37(5). 437–445. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paula R. Clemens Breakdown of academic impact, for papers by Julaine Florence Breakdown of academic impact, for papers by Pieter A. van Doorn Breakdown of academic impact, for papers by Anneke J. van der Kooi Breakdown of academic impact, for papers by Wolfgang Müller‐Felber Breakdown of academic impact, for papers by Giuseppe Vita Breakdown of academic impact, for papers by Guiting Lin Breakdown of academic impact, for papers by Izumi Nagata Breakdown of academic impact, for papers by Katherine D. Mathews Breakdown of academic impact, for papers by Elena Pegoraro
Rankless by CCL
2026